Clinical Trial: Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703280) titled 'Intra Articular Injection of Peripheral Blood Mononuclear Cells for Knee Osteoarthritis' on July 08.

Brief Summary: The goal of this Phase II/III, double-blinded, multicenter clinical trial is to assess the clinical efficacy of autologous peripheral blood mononuclear cells (PBMCs) in the management of knee osteoarthritis (KOA). The main questions it aims to answer are:

1. To determine the safety of the PCP-PBMCs injection

2. To compare the long-term efficacy between PCP-PBMCs and methylprednisolone on pain relief and motor function restoration

3. To analyze improving quality of life after the PCP-PBMCs treatment.

Study Start Dat...